WOW !! MUCH LOVE ! SO WORLD PEACE !
Fond bitcoin pour l'amélioration du site: 1memzGeKS7CB3ECNkzSn2qHwxU6NZoJ8o
  Dogecoin (tips/pourboires): DCLoo9Dd4qECqpMLurdgGnaoqbftj16Nvp


Home | Publier un mémoire | Une page au hasard

 > 

TLS, une protéine du spliceosome, est impliquée dans le mécanisme d'action de l'acide rétinoà¯que à  travers les régulations post-transcriptionnelle et transcriptionnelle


par Eric Le Corvec
Université Paris 7 - DEA Biologie des cellules sanguines 2002
  

précédent sommaire

Bitcoin is a swarm of cyber hornets serving the goddess of wisdom, feeding on the fire of truth, exponentially growing ever smarter, faster, and stronger behind a wall of encrypted energy

V - REFERENCES

Allegretto, E. A., McClurg, M. R., Lazarchik, S. B., Clemm, D. L., Kerner, S. A., Elgort, M. G., Boehm, M. F., White, S. K., Pike, J. W., and Heyman, R. A. (1993). Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. Correlation with hormone binding and effects of metabolism. J. Biol. Chem. 268, 26625-26633.

Allenby, G., Bocquel, M. T., Saunders, M., Kazmer, S., Speck, J., Rosenberger, M., Lovey, A., Kastner, P., Grippo, J. F., and Chambon, P. (1993). Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc. Natl. Acad. Sci. U.S.A. 90, 30-34.

Aman, P., Panagopoulos, I., Lassen, C., Fioretos, T., Mencinger, M., Toresson, H., Hoglund, M., Forster, A., Rabbitts, T. H., and Ron, D., (1996). Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 37, 1-8.

Beaschtold, H., Kuroda, M., Sock, J., Ron, D., and Lopez, B.L. (1999). Human 75 Kda DNA-pairing Protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J. Biol. Chem. 274, 34337-34342.

Bertolotti, A., Lutz, Y., Heard, D. J., Chambon, P., and Tora, L. (1996). hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 15, 5022-5031.

Bertolotti, A., Melot, T., Acker, J., Vigneron, M., Delattre, O., and Tora, L. (1998). EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol. Cell. Biol. 18, 1489-1497.

Bretnach, R., and Chambon, P. (1981). Organization and expression of eukaryotic split genes coding for proteins. Annu. Rev. Biochem., 50, 349-384.

Breitman, T. R., Selonick, S. E., and Collins, S. J. (1980). Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 77, 2936-2940.

Burd, C. G., and Dreyfuss, G. (1994). RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J. 13, 1197-1204.

Chambon, P. (1996). A decade of molecular biology of retinoic acid receptors. FASEB J. 10, 940-954.

Chen, Z., Brand, N.J., Chen A., Chen, S.J., Tong, J.H., Wang, Z.Y., Waxman, S., and Zelent, A. (1993). Fusion between a novel krüpper-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11 ;17) translocation associated with acute promyelocytic leukemia. EMBO J. 12, 1161-1167.

Cho, E.J., Takagi, T., Moore, C.R., Buratowski, S. (1997). mRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxy terminal domain. Genes Dev 11, 3319-3326.

Chomienne, C., Fenaux, P., and Degos, L. (1996). Retinoid differentiation therapy in promyelocytic leukemia. FASEB J. 10, 1025-1030.

Cooper, D.L., and Dougherty G.J. (1995). To metastasize or not? Selection of CD44 splice sites. Nat. Med. 1, 635-637.

Croft, L., Schandorff, S., Clark, F., Burrage, K., Arctander, P., and Mattick, J.S. (2000). ISIS, the intron information system, reveals the high frequency of alternative splicing in the human genome. Nat. Genet. 24, 340-341.

Crozat, A., Aman, P., Mandahl, N., and Ron, D. (1993). Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 640-644.

Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., and Rouleau, G. (1992). Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162-165.

Douer, D., and Koeffler, H. P. (1982). Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. J. clin. invest. 69, 277-283.

Felsenfeld, G., Boyes, J., Chung, J., Clark, D., and Studitsky, V. (1996). Chromatin structure and gene expression. Proc. natl. acad. sci. u.s.a. 93, 9384-9388.

Fenaux, P., Chastang, C., Chomienne, C. and Degos, L. (1994).All-trans retinoic acid (ATRA) in combination with chemotherapy improves survival in newly diagnosed acute promyelocytic leukemia (APL). Lancet, 343, 1033.

Ge, H., Si, Y., and Roeder, R. G. (1998). Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J. 17, 6723-6729.

Giguère, V. (1994). Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr. Rev. 15, 61-79.

Giguere, V., Ong, E. S., Segui, P., and Evans, R. M. (1987). Identification of a receptor for the morphogen retinoic acid. Nature 330, 624-629.

Gratas, C., Menot, M. L., Dresch, C., and Chomienne, C. (1993). Retinoic acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia 7, 1156-1162.

Green S. and Chambon P. (1986). Carcinogenesis: a superfamily of potentially oncogenic hormone receptors. Nature 324, 615-617.

Hallier, M., Lerga, A., Barnache, S., Tavitian, A., Moreau-Gachelin F. , (1998). The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J. Biol. Chem..273(9), 4838-42.

Hicks, G.G., Singh, N., Nashabi, A., Mai, S., Bozeck, G., Klewes, L., Arapovic, D., White, E.K., Koury, M.J., Oltz, E.M., Van Kaer, L., and Ruley, E.H. (2000). Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nature Genetics 24, 175-179.

Hirose, Y., and Manley, J.L. (1998). RNA polymerase II is an essential mRNA polyadenylation factor. Nature 395, 93-96.

Ichikawa, H., Shimizu, K., Katsu, R., and Ohki, M. (1999) Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS). Mol. Cell. Biol. 15, 2513-2526.

Kastner, P., Grondona, J. M., Mark, M., Gansmuller, A., LeMeur, M., Décimo, D., Vonesch, J. L., Dollé, P., and Chambon, P. (1994). Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 78, 987-1003.

Krust, A., Kastner, P., Petkovich, M., Zelent, A., and Chambon, P. (1989). A third human retinoic acid receptor, hRAR-gamma. Proc. natl. acad. sci. u.s.a. 86, 5310-5314.

Lerga, A., Hallier, M., Delva, L., Orvain, C., Gallais, I., Marie, J., Moreau-Gachelin F. (2001), Identification of an RNA binding specificity for the potential splicing factor TLS.J .Biol .Chem.. 276(9), 6807-16.

Mills, K.I., Walsh, V., Gilkes, A.F., Sweeney, M.C., Mirza, T., Woodgate L.J., Brown G. and Burnett A.K. (2000). High FUS/TLS expression in acute myeloid leukaemia samples. Brit. J. Hem. 108, 316-321

Misteli, T. (2000). Cell biology of transcription and pre-mRNA splicing: nuclear architecture meets nuclear function. J Cell Sci 113 11, 1841-1849.

Pereira, D.S., Dorrell, C., Ito, C.Y., Gan, O.I., Murdoch, B., Rao, V.N., Zou, J.P., Reddy, E.S., and Dick, J.E. (1998). Retroviral transduction of TLS/ERG initiates a leukemogenic program in normal human hematopoietic cells. Proc. Natl. Acad. Sci. USA 95, 8239-8244..

Perroti, D., Bonatti, S., Trotta, R., Martinez, R., Skorski, T., Salomoni, P., Grassili, E., Lozzo, R.V., Cooper,D. R., and Calabretta B. (1998). TLS/FUS a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J. 17, 4442-4455.

Petkovich, M., Brand, N.J., Krust, A., and Chambon, P. (1987). A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330, 444-450.

Philips, A. V., and Cooper, T. A. (2000). RNA processing and human disease. Cell. Mol. Life. Sci 57, 235-249.

Rabbits, T.H., Foster, A., Larson, R., Nathan P. (1993). Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignat liposarcoma. Nature Gen. 4, 175-180.

Powers, C.A., Mathur, M., Raaka, B.M., Ron, D., and Samuels, H.S. (1998). TLS (Translocated in LipoSarcoma) is a high affinity interactor for steroid, thyroid hormone and retinoid receptors. Molecular Endocrinology 12, 4-18.

Stickeler, E., Kittrell, F., Medina, D., and Berget, S.M. (1999). Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18, 3574-3582.

Umesono, K. (1998). Endocrine signaling system mediated by nuclear receptor. Nippon Rinsho 56, 1693-1698.

Uranishi, H., Tetsuka, T., Yamashita, M., Asamitsu, K., Shimizu, M., Itoh, M., and Okamoto, T. (2001). Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J. Biol Chem 276, 13395-13401.

Valcarel, J., Gaur, R.K., Singh, R., and Green, M.R. (1996). Interaction of U2AF RS region with pre-nRNA of branch point and promotion base pairing with U2snRNA. Science 273, 1706-1709.

Yang, L., Embree, L.J., and Hickstein, D.D. (2000). TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol Cell Biol 20(10), 3345-54.

Yamamoto, K., Hamagushi, H., Nagata, K., Kobayashi, M., Tanimoto, F., and Taniwaki, M. (1997), Establishment of anovel human acute myeloblastic leukemia cell line (YNH-1) with t(16;21), t(1;16) and 12q13 translocations. Leukemia 11, 599-608.

Zelenetz, A.D., Wilman, C.L., Chen, Z., Chen, S-J, Zelent, A., Macintyre, E., Veil, A., Cortes, J., Kantarjian, H. and Waxman, S. (1995) Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood, 85, 1083-1094.

Zelent, A., Krust, A., Petkovich, M., Kastner, P. and Chambon, P. (1989) Cloning of murine alpha and beta retinoic acid receptors and a novel receptor gamma predominantly expressed in skin. Nature 339, 714-717.

Zinszner, H., Albalat, R., and Ron, D. (1994). A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes and Dev 8, 2513-2526.

Zinszner, H., Immanuel, D., Yin, Y., Liang, F.X., and Ron, D. (1997). A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited. Oncogene 14, 451-461.

Zinszner, H., Sok, J., Immanuel, D., Yin, Y., and Ron, D. (1997). TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell. Sci. 110 , 1741-1750.

précédent sommaire






Bitcoin is a swarm of cyber hornets serving the goddess of wisdom, feeding on the fire of truth, exponentially growing ever smarter, faster, and stronger behind a wall of encrypted energy








"Les esprits médiocres condamnent d'ordinaire tout ce qui passe leur portée"   François de la Rochefoucauld